Japan Direct-to-Consumer Laboratory Testing Market Outlook 2031

  • The Japan direct-to-consumer laboratory testing market was valued at US$ 190.84 Mn in 2020
  • It is estimated to expand at a CAGR of 26.1% from 2021 to 2031
  • The Japan direct-to-consumer laboratory testing market is expected to cross the value of US$ 2.4 Bn by the end of 2031

Analysts’ Viewpoint on Japan Direct-to-Consumer Laboratory Testing Market Scenario

With the COVID-19 pandemic triggering interest in telehealth and consumer-initiated testing, companies in the Japan direct-to-consumer laboratory testing market are aiming to expand their DTC operations. DTC genetic testing aimed at guiding a patient’s diet or exercise remains largely unproven in producing better outcomes. Hence, market stakeholders should implement laboratory stewardship programs that improve patient-centered care. Moreover, genetic counseling sessions are being conducted to explain details and options at appropriate education levels. Mobile apps are being developed to facilitate patient retrieval of results. Healthcare providers in the Japan direct-to-consumer laboratory testing market are increasing patient access to their electronic medical records. Furthermore, educational materials are being written in patient’s language of choice. Enhanced communication between patients and physicians through text, phone, and electronic medical record is helping to improve the patient quality of life.

Patient-specific Laboratory Stewardship Programs Improving Clinical Numbers

Telehealth is making it possible for increasing the availability of direct-to-consumer (DTC) laboratory testing. Patient-centered laboratory stewardship is acting as a key driver for growth of the Japan direct-to-consumer laboratory testing market. There is a rising need for patient care that is respectful of and responsive to individual patient preferences, values, and needs. These trends are helping in ensuring that patient values guide all clinical decisions.

The concept of patient centered capitalism is storming the Japan direct-to-consumer laboratory testing market. Stakeholders are prioritizing the interests of patients over those of financial and other stakeholders within both the healthcare system & its suppliers. Patient-centered laboratory stewardship is proving beneficial to improve important areas of lab testing and DTC testing such as test ordering, result retrieval, result interpretation, and financial fairness for patients & other stakeholders.

Request a sample to get extensive insights into the Direct-to-Consumer Laboratory Testing Market

Users Prefer Convenience of COVID-19 Home Test Collection Kits

The sudden rise in coronavirus cases in India, China, and the U.K. has once again put healthcare companies in Japan under great scrutiny. Since the U.S. Food and Drug Administration (FDA) has authorized the use of COVID-19 home test collection kits, companies in the Japan direct-to-consumer laboratory testing market are taking cues from the same. Manufacturers are developing COVID-19 test home collection kits that can be used by individuals of 18 years & above without the need for a prescription.

Companies in the Japan direct-to-consumer laboratory testing market are innovating in COVID-19 test home collection kits that enable positive or invalid results that are delivered to the user by phone call from a healthcare provider or lab. Such kits are allowing users to self-collect a nasal swab sample at home and then send that sample for testing to labs.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Can DTC Testing Become Industry Norm in Future?

Risks and benefits of DTC tests are influencing the growth of the Japan market of COVID-19 home test collection kits. Convenience, low cost, and confidentiality advantages are bolstering the market growth, whereas difficult to interpret results & risk of incorrect self-diagnosis are creating concerns among individuals. Nevertheless, advantages such as non-health tests and increase in the number of people becoming health conscious tend to offset the disadvantages of DTC tests. The popularity of at-home DNA test kits is contributing to the growth of the market for direct-to-consumer laboratory testing.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Direct-to-Consumer Laboratory Testing Market

Disease Prevention with DTC Genetic Testing Benefitting Patients and Healthcare Practitioners

Personalized, precision, and genomic medicine based on DNA sequencing holds potentials to offer opportunities for improving the overall public health. The Japan direct-to-consumer laboratory testing market is undergoing significant changes with DNA sequencing being applied for disease prevention such as heart diseases, cancers, and metabolic diseases.

The identification of patients’ risk profile is becoming necessary in the Japan direct-to-consumer laboratory testing market. DTC genetic testing is giving access to information on their risks of suffering from a wide range of chronic diseases.

AI & Cloud Computing Enabling Development of Tailored Health Management Solutions

The Japan direct-to-consumer laboratory testing market is slated to clock an astonishing CAGR throughout the assessment period. Market stakeholders and telecommunication companies are anticipated to enter into collaborations to help individuals stay informed about their health status by sending lab results directly to their mobile devices.

Smartphone based healthcare services are growing prominent in the market of direct-to-consumer laboratory testing. The combination of artificial intelligence (AI) and cloud computing is being deployed for genetic decoding to provide services like tailored health management. Cloud computing is helping to store and manage personal genome analysis information.

Japan Direct-to-Consumer Laboratory Testing Market: Overview

  • Direct-to-consumer laboratory testing, also known as direct access testing, permits consumers to order laboratory tests directly from a laboratory without necessarily having to work with a healthcare provider
  • Surge in demand for early disease detection & diagnosis, increase in geriatric population, and rise in emphasis on patient-driven healthcare are projected to drive the direct-to-consumer laboratory testing market in Japan

Japan Direct-to-Consumer Laboratory Testing Market: Key Drivers

  • Increase in geriatric population susceptible to chronic illnesses drives the demand for direct-to-consumer laboratory testing. Presently, Japan is facing new problems with its medical insurance and nursing care systems for the elderly due to rapid increase in the geriatric population. DTC laboratory testing is gaining popularity among the geriatric population, which, in turn, propels the market.
  • There is a surge in emphasis on patient-driven healthcare, and direct-to-consumer laboratory testing has significantly affected patient care, its cost, and the role of the laboratory professional. Retail outlets such as Walmart, Sam’s Club, and Costco provide one-stop health care services. These services include onsite testing for glucose and cholesterol, as well as tests that are later sent out to reference laboratories.
  • Prevalence of various lifestyle-associated and infectious diseases such as obesity, hypertension, diabetes, cancer, and STD has increased. Diet is one of the key risk factors that leads to increase in the number of patients with obesity and high blood pressure. Japan's disease structure has been changing due to the rapid aging of the population and lifestyle changes.

Japan Direct-to-Consumer Laboratory Testing Market: Segmentation

  • In terms of sample type, the direct-to-consumer laboratory testing market in Japan has been classified into blood, urine, saliva, and others
  • Based on test type, the direct-to-consumer laboratory testing market in Japan has been divided into genetic testing, disease risk assessment testing, CBC, diabetes testing, TSH testing, and others
  • Each of the segments has been analyzed in detail for direct-to-consumer laboratory testing trends, recent trends & developments, drivers, restraints, opportunities, and useful insights. The direct-to-consumer laboratory testing market report provides current and future revenue (US$ Mn) for each of these segments for the period from 2017 to 2031, considering 2020 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2021 to 2031 along with market size estimations.

Major Players

  • The report concludes with the company profiles section that includes key information about the major players in the direct-to-consumer laboratory testing market in Japan
  • Key players in the market include
    • Quest Diagnostics Incorporated
    • WellnessFX
    • Ulta Lab Tests, LLC
    • Walk-In Lab, LLC
    • Genesis Healthcare Co.
    • MyHeritage Ltd.
    • Gene by Gene, Ltd.
    • Full Genomes Corporation, Inc.
    • OME Care
  • Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Japan Direct-to-Consumer Laboratory Testing Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 190.84 Mn

Market Forecast Value in 2031

US$ 2,471.01 Mn

Growth Rate (CAGR)

26.1%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment as well as country level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Sample Type
    • Blood
    • Urine
    • Saliva
    • Others
  • Test Type
    • Genetic Testing
    • Disease Risk Assessment Testing
      • Cancer
      • STDs
      • Others
    • CBC
    • Diabetes Testing
    • TSH Testing
    • Others

Country Covered

Japan

Companies Profiled

  • Quest Diagnostics Incorporated
  • WellnessFX
  • Ulta Lab Tests, LLC
  • Walk-In Lab, LLC
  • Genesis Healthcare Co.
  • MyHeritage Ltd.
  • Gene by Gene, Ltd.
  • Full Genomes Corporation, Inc.
  • OME Care
  • Other prominent players

Customization Scope

Available upon request

Pricing

Available upon request

Japan Direct-to-Consumer Laboratory Testing Market – Scope of Report

TMR’s report on the direct-to-consumer laboratory testing market in Japan studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the direct-to-consumer laboratory testing market in Japan for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the direct-to-consumer laboratory testing market in Japan from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the direct-to-consumer laboratory testing market in Japan.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the direct-to-consumer laboratory testing market in Japan.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the direct-to-consumer laboratory testing market in Japan. These serve as valuable tools for existing market players as well as for entities interested in participating in the direct-to-consumer laboratory testing market in Japan.

The report delves into the competitive landscape of the direct-to-consumer laboratory testing market in Japan. Key players operating in the direct-to-consumer laboratory testing market in Japan have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the direct-to-consumer laboratory testing market in Japan profiled in this report.

Key Questions Answered in Japan Direct-to-Consumer Laboratory Testing Market Report

  • What is the sales/revenue generated by direct-to-consumer laboratory testing in Japan during the forecast period?
  • What are the opportunities in the direct-to-consumer laboratory testing market in Japan?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Is market set to expand at the fastest CAGR during the forecast period?
  • Which sample type is expected to generate the highest revenue in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What is the market position of different companies operating in the market?

Japan Direct-to-Consumer Laboratory Testing Market – Research Objectives and Research Approach

The comprehensive report on the direct-to-consumer laboratory testing market in Japan begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the direct-to-consumer laboratory testing market in Japan, in terms of sample type, test type, and region. Key segments under each criterion are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the direct-to-consumer laboratory testing market in Japan.

Japan Direct-to-Consumer Laboratory Testing Market – Segmentation

TMR’s study on the direct-to-consumer laboratory testing market in Japan includes information divided into three segments: sample type, test type, and region. Changing industry trends and other crucial market dynamics associated with these segments of the direct-to-consumer laboratory testing market in Japan are discussed in detail.

Sample Type
  • Blood
  • Urine
  • Saliva
  • Others
Test Type
  • Genetic Testing
  • Disease Risk Assessment Testing
    • Cancer
    • STDs
    • Others
  • CBC
  • Diabetes Testing
  • TSH Testing
  • Others
Country Japan

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Japan Direct-to-Consumer Laboratory Testing Market

4. Market Overview

    4.1. Introduction

        4.1.1. Sample Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Japan Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Disease Epidemiology

    5.2. Regulatory Scenario by Country

    5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)

    5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Japan Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Sample Type, 2017–2031

        6.3.1. Blood

        6.3.2. Urine

        6.3.3. Saliva

        6.3.4. Others

    6.4. Market Attractiveness Analysis, by Sample Type

7. Japan Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Test Type, 2017–2031

        7.3.1. Genetic Testing

        7.3.2. Disease Risk Assessment Testing

            7.3.2.1. Cancer

            7.3.2.2. STDs

            7.3.2.3. Others

        7.3.3. CBC

        7.3.4. TSH Testing

        7.3.5. Diabetes Testing

        7.3.6. Others

    7.4. Market Attractiveness Analysis, by Test Type

8. Japan Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. Japan

    8.3. Market Attractiveness Analysis, by Country/Region

9. Competition Landscape

    9.1. Market Player – Competition Matrix (by tier and size of companies)

    9.2. Company Profiles

        9.2.1. Quest Diagnostics Incorporated

            9.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            9.2.1.2. Product Portfolio

            9.2.1.3. Financial Overview

            9.2.1.4. Strategic Overview

            9.2.1.5. SWOT Analysis

        9.2.2. WellnessFX

            9.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            9.2.2.2. Product Portfolio

            9.2.2.3. Financial Overview

            9.2.2.4. Strategic Overview

            9.2.2.5. SWOT Analysis

        9.2.3. Ulta Lab Tests, LLC

            9.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            9.2.3.2. Product Portfolio

            9.2.3.3. Financial Overview

            9.2.3.4. Strategic Overview

            9.2.3.5. SWOT Analysis

        9.2.4. Walk-In Lab, LLC

            9.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            9.2.4.2. Product Portfolio

            9.2.4.3. Financial Overview

            9.2.4.4. Strategic Overview

            9.2.4.5. SWOT Analysis

        9.2.5. Genesis Healthcare Co.

            9.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            9.2.5.2. Product Portfolio

            9.2.5.3. Financial Overview

            9.2.5.4. Strategic Overview

            9.2.5.5. SWOT Analysis

        9.2.6. MyHeritage Ltd.

            9.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            9.2.6.2. Product Portfolio

            9.2.6.3. Financial Overview

            9.2.6.4. Strategic Overview

            9.2.6.5. SWOT Analysis

        9.2.7. Gene by Gene, Ltd.

            9.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            9.2.7.2. Product Portfolio

            9.2.7.3. Financial Overview

            9.2.7.4. Strategic Overview

            9.2.7.5. SWOT Analysis

        9.2.8. Full Genomes Corporation, Inc.

            9.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            9.2.8.2. Product Portfolio

            9.2.8.3. Financial Overview

            9.2.8.4. Strategic Overview

            9.2.8.5. SWOT Analysis

        9.2.9. OME Care

            9.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            9.2.9.2. Product Portfolio

            9.2.9.3. Financial Overview

            9.2.9.4. Strategic Overview

            9.2.9.5. SWOT Analysis

List of Tables

Table 01: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 02: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 03: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 04: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Country, 2017–2031

List of Figures

Figure 01: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Japan Direct-to-Consumer Laboratory Testing Market Value Share, by Sample Type, 2020

Figure 03: Japan Direct-to-Consumer Laboratory Testing Market Value Share, by Test Type, 2020

Figure 04: Japan Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2021 and 2031

Figure 05: Japan Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2017–2031

Figure 06: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Blood, 2017–2031

Figure 07: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine. 2017–2031

Figure 08: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Saliva, 2017–2031

Figure 09: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 10: Japan Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2021 and 2031

Figure 11: Japan Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2017–2031

Figure 12: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Genetic Testing, 2017–2031

Figure 13: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Disease Risk Assessment Testing, 2017–2031

Figure 14: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by CBC, 2017–2031

Figure 15: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Diabetes Testing, 2017–2031

Figure 16: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by TSH Testing, 2017–2031

Figure 17: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 18: Japan Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Country, 2021 and 2031

Figure 19: Japan Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Country, 2017–2031

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Japan Direct-to-Consumer Laboratory Testing Market